M10, a novel derivative of Myricetin, prevents ER stress-induced autophagy in inflamed colonic mucosal cells by targeting the NF-κB/IL-6/STAT3 pathway, which develops M10 as a promising regimen in the chemoprevention of colitis and colorectal cancer [66]. This evidence concerns the gene NFKB1 and colitis.